NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc.") (NYSE: INSP ) concerning possible violations of federal securities laws. On August 5, 2025, Inspire issued a press release announcing better-than-expected second quarter fiscal 2025 results, but surprisingly also slashed its full-year guidance from anticipated earnings of $2.20 - $2.30 on revenue of $940m - $955m down to earnings of $0.40 - $0.50 on revenue of $900m - $910m. This follows Inspire raising its earnings guidance only one quarter ago. Management blamed the guidance setback on slowdowns related to the recent rollout of Inspire V.